Novartis opens new manufacturing plant in Mumbai to make generic cancer drugsSpread across 32,000 sqm, and housing state-of-the-art production technology, the plant is built to cater to export markets. It currently h...
Novartis India enters distribution pact with DRL for top brands, to lay off 400 employeesNovartis India said its strategic business decision will lead to the separation of approximately 400 employees due to role redundancies.
Taken remedial actions at two plants in Maharashtra: Drug firm NovartisOn October 22, 2015, the USFDA had issued a warning letter to the company's Sandoz Division concerning Indian sites in Kalwe and Turbhe.
Novartis gets USFDA warning letter for two plants in IndiaSandoz, the generic drug arm of Swiss drug major Novartis, has received a warning letter from the US health regulator for violations of cur...
Sandoz gets US FDA warning letter for Turbhe, Kalwe sitesThe observations in the warning letter dated October 22 are related to deficiencies in current good manufacturing practice (cGMP) for finis...
Sandoz gets warning letter for Turbhe, Kalwe siteSandoz, the generic drug arm of Swiss giant Novartis, has received a warning letter from the US FDA on October 22 for its two Indian sites ...
- Mukand may offer equity stake to Bosch India
The Rahul Bajaj-controlled speciality steel company Mukand is considering making an equity offer to German auto component maker Bosch India.
- TEVA TO buy local unit for Rs 400 cr
The world’s largest generic drug manufacturer Teva may be close to acquiring domestic company Saraca Labs’ manufacturing plant in Hyderabad...